share_log

Gain Therapeutics(GANX.US) Director Buys US$20,670 in Common Stock

Moomoo News ·  Jul 1 17:42

$Gain Therapeutics (GANX.US)$ Director RICHMAN ERIC I purchased 17,000 shares of common stock on Jul 1, 2024 at an average price of $1.22 for a total value of $20,670.

1719870175213890930.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment